The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens that record information such as when and how much insulin is administered, with the data uploaded to an app ...

DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose ...

and NovoPen Echo Plus, expanding its utility. Dexcom also remains the only CGM provider offering data-sharing capabilities via the Follow app, enabling remote glucose monitoring for caregivers.

Launch of the NovoPen 6 and NovoPen Echo Plus will begin in the first quarter of 2019 and roll out to over 50 countries in the coming years. The new pens will eventually be phased in to replace ...

By seamlessly integrating Dexcom CGM data with NovoPen® 6 and NovoPen Echo® Plus insulin data in one app, healthcare professionals gain a comprehensive, actionable view of a patient’s glucose ...